NASDAQ:NTRA Natera Q3 2025 Earnings Report $172.81 -1.36 (-0.78%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$171.70 -1.12 (-0.65%) As of 10/14/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast Natera EPS ResultsActual EPSN/AConsensus EPS -$0.40Beat/MissN/AOne Year Ago EPSN/ANatera Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ANatera Announcement DetailsQuarterQ3 2025Date11/11/2025TimeAfter Market ClosesConference Call DateTuesday, November 11, 2025Conference Call Time4:30PM ETConference Call ResourcesEarnings HistoryCompany Profile Natera Earnings HeadlinesNatera Shows Improved Relative Price Performance; Still Shy Of Benchmark4 hours ago | msn.comCanaccord Genuity Maintains Natera (NTRA) Buy Recommendation4 hours ago | msn.comWhy I'm avoiding Nvidia (and buying these 3 AI stocks instead)Everyone's buying Nvidia. The financial media can't stop talking about it. Your neighbor probably owns it. That's exactly why I'm looking elsewhere. See, when everyone piles into the same trade, the easy money is already gone. The real profits come from finding what the crowd is missing. | TradingTips (Ad)Natera Signatera Validation Study Published in JCO PO Shows Superior Prognostic Value in Testicular CancerOctober 13 at 12:34 PM | msn.comThe Bull Case For Natera (NTRA) Could Change Following Breakthrough Study Results for Signatera PlatformOctober 13 at 12:34 PM | finance.yahoo.comNatera to Host Investor Call on October 23, 2025 to Discuss ESMO FindingsOctober 13 at 8:20 AM | businesswire.comSee More Natera Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Natera? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Natera and other key companies, straight to your email. Email Address About NateraNatera (NASDAQ:NTRA) is a global molecular diagnostics company headquartered in San Carlos, California. Founded in 2004 by Matthew Rabinowitz and Jonathan Sheena, the company specializes in developing and commercializing non-invasive genetic testing technologies. Natera’s platform leverages proprietary DNA analysis and bioinformatics to deliver insights across reproductive health, oncology and organ transplantation without the need for invasive procedures. In the reproductive health arena, Natera’s flagship product is the Panorama™ non-invasive prenatal test (NIPT), which screens for fetal chromosomal abnormalities as early as ten weeks into pregnancy. The company also offers Horizon™ carrier screening for inherited single-gene disorders, enabling prospective parents to understand their genetic risk prior to conception or early in gestation. Within oncology, Natera markets Signatera™, a personalized circulating tumor DNA (ctDNA) assay designed to detect minimal residual disease (MRD) and monitor treatment response in a variety of cancers. For organ transplantation, the Prospera™ assay quantifies donor-derived cell-free DNA to assess the risk of graft rejection. These tests aim to provide clinicians with actionable data to guide patient management and therapeutic decisions. Natera went public on the Nasdaq stock exchange in December 2015 and has since expanded its testing services into Europe, Asia-Pacific and Latin America. Its centralized laboratories and global partnerships support thousands of healthcare providers and research institutions. The company continues to invest in R&D to enhance its genomics platform under the leadership of founder and Chief Scientific Officer Matthew Rabinowitz and an experienced executive team.View Natera ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of EarningsTesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff Concerns Upcoming Earnings ASML (10/15/2025)Abbott Laboratories (10/15/2025)Bank of America (10/15/2025)Kinder Morgan (10/15/2025)Morgan Stanley (10/15/2025)Progressive (10/15/2025)Prologis (10/15/2025)The PNC Financial Services Group (10/15/2025)CSX (10/16/2025)Interactive Brokers Group (10/16/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
